Insights

Acquisition Opportunity Optivia Biotechnology was acquired by BioIVT in 2018, indicating integration into a larger CRO network. This presents a sales opportunity to align with BioIVT’s expanded transporter assay capabilities and cross-sell integrated transporter screening services to their established client base.

Niche Transporter Experts specialize in transporter screening and DDI, DMPK, safety, and pharmacology assays. Target biotech and pharma companies seeking predictive transporter-related data and customized solutions to de-risk development programs.

Small Team, Niche Focus With a compact 2-10 employee base and a specialized service line, Optivia may be highly agile but may benefit from partnerships with larger CROs or tech-enabled platforms to scale outreach and project capacity.

Technology Stack Utilizes common digital marketing and engagement tools (WordPress, HubSpot, Mailchimp, Yoast) suggesting readiness for outbound campaigns, landing pages, and CRM-driven lead nurturing to capture biopharma interest in transporter assays.

Product Milestone Notable for launching the TransFlex transporter assay system in 2016, signaling a track record of innovative assay development. Focus sales on advanced, predictive transporter solutions and long-term collaborations around assay platforms.

Similar companies to Optivia Biotechnology

Optivia Biotechnology Tech Stack

Optivia Biotechnology uses 8 technology products and services including WordPress, Mailchimp, Google Fonts API, and more. Explore Optivia Biotechnology's tech stack below.

  • Content Management System
  • Google Fonts API
    Font Scripts
  • Twemoji
    Font Scripts
  • Video.js
    Javascript Libraries
  • Marketing Automation
  • Yoast SEO
    Search Engines
  • System Analytics & Monitoring

Optivia Biotechnology's Email Address Formats

Optivia Biotechnology uses at least 2 email formats:
Optivia Biotechnology Email FormatsExamplePercentage
FLast@optiviabio.comJDoe@optiviabio.com
85%
Last@optiviabio.comDoe@optiviabio.com
15%

Frequently Asked Questions

What is Optivia Biotechnology's phone number?

Minus sign iconPlus sign icon
You can contact Optivia Biotechnology's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Optivia Biotechnology's official website and social media links?

Minus sign iconPlus sign icon
Optivia Biotechnology's official website is optiviabio.com and has social profiles on LinkedIn.

How much revenue does Optivia Biotechnology generate?

Minus sign iconPlus sign icon
As of August 2026, Optivia Biotechnology's annual revenue is estimated to be $1M - $10M.

What is Optivia Biotechnology's NAICS code?

Minus sign iconPlus sign icon
Optivia Biotechnology's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Optivia Biotechnology have currently?

Minus sign iconPlus sign icon
As of August 2026, Optivia Biotechnology has approximately 5 employees across 1 continents, including North America. Key team members include Chief Financial Officer: D. P., Chief Technology Officer: J. S. and Director Business Development: D. S. Explore Optivia Biotechnology's employee directory with LeadIQ.

What industry does Optivia Biotechnology belong to?

Minus sign iconPlus sign icon
Optivia Biotechnology operates in the Pharmaceutical Manufacturing industry.

What technology does Optivia Biotechnology use?

Minus sign iconPlus sign icon
Optivia Biotechnology's tech stack includes WordPress, Mailchimp, Google Fonts API, Twemoji, Video.js, HubSpot, Yoast SEO and Piwik.

What is Optivia Biotechnology's email format?

Minus sign iconPlus sign icon
Optivia Biotechnology's email format typically follows the pattern of FLast@optiviabio.com. Find more Optivia Biotechnology email formats with LeadIQ.

When was Optivia Biotechnology founded?

Minus sign iconPlus sign icon
Optivia Biotechnology was founded in 2007.
Optivia Biotechnology logo

Optivia Biotechnology

Pharmaceutical ManufacturingCalifornia, United States2-10 Employees

Optivia Biotechnology is a contract research organization based in Santa Clara, California, offering transporter screening services and related solutions that address drug-drug interaction, DMPK, safety, and pharmacology concerns. The company provides transporter-focused assays, informatics products, and customized services aimed at biotechnology, pharmaceutical, and academic customers seeking predictive, best-in-class research support in drug transport mechanisms. Its offerings are positioned to support decision-making across preclinical and early development stages by delivering comprehensive research services and tailored solutions in transporter biology. Optivia’s market footprint places it within the pharmaceutical manufacturing and CRO sector, with a history tied to the development and launch of transporter assay platforms, such as the TransFlex system, and a profile indicating collaboration with industry players in related spaces. The organization is based in Santa Clara, and has historically operated as a small specialized provider within the broader life sciences services landscape. A notable development in its recent history is its acquisition by BioIVT in 2018, signaling integration into a larger CRO platform while continuing to offer transporter-focused research capabilities.

Section iconCompany Overview

Phone number
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2007
Employees
2-10

Section iconFunding & Financials

  • $1M - $10M

    Optivia Biotechnology's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.